Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 14
Original Research
Clinical and Economic Benefits of Lenzilumab Plus Standard of Care Compared with Standard of Care Alone for the Treatment of Hospitalized Patients with Coronavirus Disease 19 (COVID-19) from the Perspective of National Health Service England
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,815 | Dovepress* | 8,536+ | 396 | 8,932 | |
| PubMed Central* | 279 | 108 | 387 | ||
| Totals | 8,815 | 504 | 9,319 | ||
| *Since 14 April 2022 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 134 | 0 | 0 | 0 | 17 | 117 |
View citations on PubMed Central and Google Scholar